hepatoАнналы хирургической гепатологииAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery1995-54642408-9524НЭИКОН ИСП10.16931/1995-5464.2022-1-64-71hepato-775Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEWSПрогнозирование и профилактика тяжелых осложнений при радикальном хирургическом лечении воротной холангиокарциномыPrediction and prevention of severe complications following radical surgical treatment of hilar cholangiocarcinomahttps://orcid.org/0000-0002-8352-9748ЗамановЭ. Н.ZamanovE. N.

Заманов Эхтибар Низамиевич – врач-хирург, хирургическое отделение №1

115682, Москва, ул. Ореховый бульвар, д. 28

Ekhtibar N. Zamanov – MD, Surgeon, Department of Surgery No. 1, Federal Scientific and Clinical Center

28, Orekhovy bulvar, 115682, Moscow

ehtibar87@mail.ruhttps://orcid.org/0000-0003-0738-7642ЕфановМ. Г.EfanovM. G.

Ефанов Михаил Германович – доктор мед. наук, руководитель отдела гепатопанкреатобилиарной хирургии

111123, Москва, шоссе Энтузиастов, д. 86

Mikhail G. Efanov – Doct. of Sci. (Med.), Head of the Department of Hepatopancreatobiliary Surgery

86, Shosse Entuziastov, 111123

m.efanov@mknc.ruФГБУ “Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий” ФМБА РоссииРоссияFederal Scientific and Clinical Center of Specialized Types of Medical Care and Medical Technologies, Federal Medical Biological Agency of RussiaRussian FederationГБУЗ “Московский клинический научный центр им. А.С. Логинова” ДЗМРоссияA.S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare DepartmentRussian Federation2022090220222716471Copyright © Заманов Э.Н., Ефанов М.Г., 20222022Заманов Э.Н., Ефанов М.Г.Zamanov E.N., Efanov M.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://hepato.elpub.ru/jour/article/view/775

В обзоре литературы освещены последние достижения в профилактике и прогнозировании гнойно-септических осложнений, пострезекционной печеночной недостаточности и других тяжелых послеоперационных последствий радикального хирургического лечения больных воротной холангиокарциномой. Сведения, полученные при анализе современной литературы, свидетельствуют об актуальности этой проблемы. Приоритетным направлением является поиск комбинированных методов оценки риска развития периоперационных осложнений.

This literature review highlights the recent advances in the prevention and prognosis of purulent-septic complications, post-resection liver failure, and other severe postoperative complications following the surgical treatment of hilar cholangiocarcinoma. The data obtained from the analysis of the recent scientific publications indicate the relevance of this problem. Research should be prioritized to formulate combined methods that can assess the risk of perioperative complications.

печеньжелчные протокиворотная холангиокарциномагнойно-септические осложненияпеченочная недостаточностьпрогнозированиеоценка рискаliverbile ductshilar cholangiocarcinomapurulent-septic complicationsliver failureprognosisrisk assessmentReferencesВишневский В.А., Коваленко Ю.А., Андрейцева О.И., Икрамов Р.З., Ефанов М.Г., Назаренко Н.А., Тупикин К.А. Пострезекционная печеночная недостаточность: современные проблемы определения, эпидемиологии, патогенеза, оценки факторов риска, профилактики и лечения. Український журнал хірургії. 2013; (3): 172–182.Vishnevskij V.A., Kovalenko Yu.A., Andrejceva O.I., Ikramov R.Z., Efanov M.G., Nazarenko N.A., Tupikin K.A. Postresection liver failure: modern problems of definition, epidemiology, pathogenesis, risk factors assessment, prevention and treatment. Ukraininan Journal of Surgery. 2013; (3): 172– 182. (In Russian)Coelen R.J., Olthof P.B., van Dieren S., Besselink M.G., Busch O.R., van Gulik T.M. External validation of the estimation of physiologic ability and surgical stress (E-PASS) risk model to predict operative risk in perihilar cholangiocarcinoma. JAMA Surg. 2016; 151 (12): 1132–1138. https://doi.org/10.1001/jamasurg.2016.2305Coelen R.J., Olthof P.B., van Dieren S., Besselink M.G., Busch O.R., van Gulik T.M. External validation of the estimation of physiologic ability and surgical stress (E-PASS) risk model to predict operative risk in perihilar cholangiocarcinoma. JAMA Surg. 2016; 151 (12): 1132–1138. https://doi.org/10.1001/jamasurg.2016.2305Ito F., Cho C.S., Rikkers L.F., Weber S.M. Hilar cholangiocarcinoma: current management. Ann. Surg. 2009; 250 (2): 210–218. https://doi.org/10.1097/sla.0b013e3181afe0abIto F., Cho C.S., Rikkers L.F., Weber S.M. Hilar cholangiocarcinoma: current management. Ann. Surg. 2009; 250 (2): 210–218. https://doi.org/10.1097/sla.0b013e3181afe0abWiggers J.K., Groot Koerkamp B., Cieslak K.P., Doussot A., van Klaveren D., Allen P.J. Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant. J. Am. Coll. Surg. 2016; 223 (2): 321–331e1. https://doi.org/10.1016/j.jamcollsurg.2016.03.035Wiggers J.K., Groot Koerkamp B., Cieslak K.P., Doussot A., van Klaveren D., Allen P.J. Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant. J. Am. Coll. Surg. 2016; 223 (2): 321–331e1. https://doi.org/10.1016/j.jamcollsurg.2016.03.035Liu Y., Wang J.Y., Jiang W. An increasing prominent disease of Klebsiella pneumoniae liver abscess: etiology, diagnosis, and treatment. Gastroenterol. Res. Pract. 2013; 2013: 258514. https://doi.org/10.1155/2013/258514Liu Y., Wang J.Y., Jiang W. An increasing prominent disease of Klebsiella pneumoniae liver abscess: etiology, diagnosis, and treatment. Gastroenterol. Res. Pract. 2013; 2013: 258514. https://doi.org/10.1155/2013/258514Olthof P.B., Wiggers J.K., Groot Koerkamp B., Coelen R.J., Allen P.J., Besselink M.G., Busch O.R., D'Angelica M.I., DeMatteo R.P., Kingham T.P., van Lienden K.P., Jarnagin W.R., van Gulik T.M. Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization. J. Am. Coll. Surg. 2017; 225 (3): 387–394. https://doi.org/10.1016/j.jamcollsurg.2017.06.007Olthof P.B., Wiggers J.K., Groot Koerkamp B., Coelen R.J., Allen P.J., Besselink M.G., Busch O.R., D'Angelica M.I., DeMatteo R.P., Kingham T.P., van Lienden K.P., Jarnagin W.R., van Gulik T.M. Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization. J. Am. Coll. Surg. 2017; 225 (3): 387–394. https://doi.org/10.1016/j.jamcollsurg.2017.06.007Lee F., Ohanian E., Rheem J., Laine L., Che K., Kim J.J. Delayed endoscopic retrograde cholangiopancreatography is associated with persistent organ failure in hospitalised patients with acute cholangitis. Aliment. Pharmacol. Ther. 2015; 42 (2): 212–220. https://doi.org/10.1111/apt.13253Lee F., Ohanian E., Rheem J., Laine L., Che K., Kim J.J. Delayed endoscopic retrograde cholangiopancreatography is associated with persistent organ failure in hospitalised patients with acute cholangitis. Aliment. Pharmacol. Ther. 2015; 42 (2): 212–220. https://doi.org/10.1111/apt.13253Lee J.G. Diagnosis and management of acute cholangitis. Nat. Rev. Gastroenterol. Hepatol. 2009; 6 (9): 533–541. https://doi.org/10.1038/nrgastro.2009.126Lee J.G. Diagnosis and management of acute cholangitis. Nat. Rev. Gastroenterol. Hepatol. 2009; 6 (9): 533–541. https://doi.org/10.1038/nrgastro.2009.126Mosler P. Diagnosis and management of acute cholangitis. Curr. Gastroenterol. Rep. 2011; 13 (2): 166–172. https://doi.org/10.1007/s11894-010-0171-7Mosler P. Diagnosis and management of acute cholangitis. Curr. Gastroenterol. Rep. 2011; 13 (2): 166–172. https://doi.org/10.1007/s11894-010-0171-7Nagino M., Hirano S., Yoshitomi H., Aoki T., Uesaka K., Unno M., Ebata T., Konishi M., Sano K., Shimada K., Shimizu H., Higuchi R., Wakai T., Isayama H., Okusaka T., Tsuyuguchi T., Hirooka Y., Furuse J., Maguchi H., Suzuki K., Yamazaki H., Kijima H., Yanagisawa A., Yoshida M., Yokoyama Y., Mizuno T., Endo I. Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition. J. Hepatobiliary Pancreat. Sci. 2021; 28 (1): 26–54. https://doi.org/10.1002/jhbp.870Nagino M., Hirano S., Yoshitomi H., Aoki T., Uesaka K., Unno M., Ebata T., Konishi M., Sano K., Shimada K., Shimizu H., Higuchi R., Wakai T., Isayama H., Okusaka T., Tsuyuguchi T., Hirooka Y., Furuse J., Maguchi H., Suzuki K., Yamazaki H., Kijima H., Yanagisawa A., Yoshida M., Yokoyama Y., Mizuno T., Endo I. Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition. J. Hepatobiliary Pancreat. Sci. 2021; 28 (1): 26–54. https://doi.org/10.1002/jhbp.870Wiggers J.K., Groot Koerkamp B., Coelen R.J., Doussot A., van Dieren S., Rauws E.A., Schattner M.A., van Lienden K.P., Brown K.T., Besselink M.G., van Tienhoven G., Allen P.J., Busch O.R., D'Angelica M.I., DeMatteo R.P., Gouma D.J., Kingham T.P., Verheij J., Jarnagin W.R., van Gulik T.M. Percutaneous preoperative biliary drainage for resectable perihilar cholangiocarcinoma: no association with survival and no increase in seeding metastases. Ann. Surg. Oncol. 2015; 22 (Suppl. 3): S1156–1163. https://doi.org/10.1245/s10434-015-4676-zWiggers J.K., Groot Koerkamp B., Coelen R.J., Doussot A., van Dieren S., Rauws E.A., Schattner M.A., van Lienden K.P., Brown K.T., Besselink M.G., van Tienhoven G., Allen P.J., Busch O.R., D'Angelica M.I., DeMatteo R.P., Gouma D.J., Kingham T.P., Verheij J., Jarnagin W.R., van Gulik T.M. Percutaneous preoperative biliary drainage for resectable perihilar cholangiocarcinoma: no association with survival and no increase in seeding metastases. Ann. Surg. Oncol. 2015; 22 (Suppl. 3): S1156–1163. https://doi.org/10.1245/s10434-015-4676-zZhang X.F., Beal E.W., Merath K., Ethun C.G., Salem A., Weber S.M., Tran T., Poultsides G., Son A.Y., Hatzaras I., Jin L., Fields R.C., Weiss M., Scoggins C., Martin R.C.G., Isom C.A., Idrees K., Mogal H.D., Shen P., Maithel S.K., Schmidt C.R., Pawlik T.M.J. Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: percutaneous biliary drainage has no adverse effects on survival. Surg. Oncol. 2018; 117 (6): 1267–1277. https://doi.org/10.1002/jso.24945Zhang X.F., Beal E.W., Merath K., Ethun C.G., Salem A., Weber S.M., Tran T., Poultsides G., Son A.Y., Hatzaras I., Jin L., Fields R.C., Weiss M., Scoggins C., Martin R.C.G., Isom C.A., Idrees K., Mogal H.D., Shen P., Maithel S.K., Schmidt C.R., Pawlik T.M.J. Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: percutaneous biliary drainage has no adverse effects on survival. Surg. Oncol. 2018; 117 (6): 1267–1277. https://doi.org/10.1002/jso.24945Coelen R.J.S., Roos E., Wiggers J.K., Besselink M.G., Buis C.I., Busch O.R.C., Dejong C.H.C., van Delden O.M., van Eijck C.H.J., Fockens P., Gouma D.J., Koerkamp B.G., de Haan M.W., van Hooft J.E., Izermans J.N.M., Kater G.M., Koornstra J.J., van Lienden K.P., Moelker A., Damink S.W.M.O., Poley J.W., Porte R.J., de Ridder R.J., Verheij J., van Woerden V., Rauws E.A.J., Dijkgraaf M.G.W., van Gulik T.M. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial. Lancet Gastroenterol. Hepatol. 2018; 3 (10): 681–690. https://doi.org/10.1016/S2468-1253(18)30234-6Coelen R.J.S., Roos E., Wiggers J.K., Besselink M.G., Buis C.I., Busch O.R.C., Dejong C.H.C., van Delden O.M., van Eijck C.H.J., Fockens P., Gouma D.J., Koerkamp B.G., de Haan M.W., van Hooft J.E., Izermans J.N.M., Kater G.M., Koornstra J.J., van Lienden K.P., Moelker A., Damink S.W.M.O., Poley J.W., Porte R.J., de Ridder R.J., Verheij J., van Woerden V., Rauws E.A.J., Dijkgraaf M.G.W., van Gulik T.M. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial. Lancet Gastroenterol. Hepatol. 2018; 3 (10): 681–690. https://doi.org/10.1016/S2468-1253(18)30234-6Tang Z., Yang Y., Meng W., Li X. Best option for preoperative biliary drainage in Klatskin tumor: a systematic review and metaanalysis. Medicine (Baltimore). 2017; 96 (43): e8372. https://doi.org/10.1097/MD.0000000000008372Tang Z., Yang Y., Meng W., Li X. Best option for preoperative biliary drainage in Klatskin tumor: a systematic review and metaanalysis. Medicine (Baltimore). 2017; 96 (43): e8372. https://doi.org/10.1097/MD.0000000000008372Liu J.G., Wu J., Wang J., Shu G.M., Wang Y.J., Lou C., Zhang J., Du Z. Endoscopic biliary drainage versus percutaneous transhepatic biliary drainage in patients with resectable hilar cholangiocarcinoma: a systematic review and meta-analysis. J. Laparoendosc. Adv. Surg. Tech. A. 2018; 28 (9): 1053–1060. https://doi.org/10.1089/lap.2017.0744Liu J.G., Wu J., Wang J., Shu G.M., Wang Y.J., Lou C., Zhang J., Du Z. Endoscopic biliary drainage versus percutaneous transhepatic biliary drainage in patients with resectable hilar cholangiocarcinoma: a systematic review and meta-analysis. J. Laparoendosc. Adv. Surg. Tech. A. 2018; 28 (9): 1053–1060. https://doi.org/10.1089/lap.2017.0744Хатьков И.Е., Аванесян Р.Г., Ахаладзе Г.Г., Бебуришвили А.Г., Буланов А.Ю., Быков М.И., Виршке Э.Г., Габриэль С.А., Гранов Д.А., Дарвин В.В., Долгушин Б.И., Дюжева Т.Г., Ефанов М.Г., Коробко В.Л., Королев М.П., Кулабухов В.В., Майстренко Н.А., Мелехина О.В., Недолужко И.Ю., Охотников О.И., Погребняков В.Ю., Поликарпов А.А., Прудков М.И., Ратников В.А., Солодинина Е.Н., Степанова Ю.А., Субботин В.В., Федоров Е.Д., Шабунин А.В., Шаповальянц С.Г., Шулутко А.М., Шишин К.В., Цвиркун В.Н., Чжао А.В., Кулезнева Ю.В. Российский консенсус по актуальным вопросам диагностики и лечения синдрома механической желтухи. Хирургия. Журнал им. Н.И. Пирогова. 2020; 6: 5–17. https://doi.org/10.17116/hirurgia20200615Khat’kov I.E., Avanesyan R.G., Akhaladze G.G., Beburishvili A.G., Bulanov A.Yu., Bykov M.I., Virshke E.G., Gabri l' S.A., Granov D.A., Darvin V.V., Dolgushin B.I., Dyuzheva Т.G., Efanov M.G., Korobko V.L., Korolev M.P., Kulabukhov V.V., Maistrenko N.A., Melekhina O.V., Nedoluzhko I.Iu., Okhotnikov O.I., Pogrebnyakov V.Yu., Polikarpov A.A., Prudkov M.I., Ratnikov V.A., Solodinina E.N., Stepanova Yu.A., Subbotin V.V., Fedorov E.D., Shabunin A.V., Shapoval’yants S.G., Shulutko A.M., Shishin K.V., Tsvirkun V.N., Chzhao A.V., Kulezneva Iu.V. Russian consensus on current issues in the diagnosis and treatment of obstructive jaundice syndrome. Pirogov Russian Journal of Surgery = Khirurgiya. Zhurnal im. N.I. Pirogova. 2020; 6: 5–17. https://doi.org/10.17116/hirurgia20200615Nimura Y. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB. 2008; 10 (2): 130–133. https://doi.org/10.1080/13651820801992666Nimura Y. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB. 2008; 10 (2): 130–133. https://doi.org/10.1080/13651820801992666Neuhaus P., Jonas S., Bechstein W.O., Lohmann R., Radke C., Kling N., Wex C., Lobeck H., Hintze R. Extended resections for hilar cholangiocarcinoma. Ann. Surg. 1999; 230 (6): 808–819. https://doi.org/10.1097/00000658-199912000-00010Neuhaus P., Jonas S., Bechstein W.O., Lohmann R., Radke C., Kling N., Wex C., Lobeck H., Hintze R. Extended resections for hilar cholangiocarcinoma. Ann. Surg. 1999; 230 (6): 808–819. https://doi.org/10.1097/00000658-199912000-00010Ferrero A., Lo Tesoriere R., Viganò L., Caggiano L., Sgotto E., Capussotti L. Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J. Surg. 2009; 33 (2): 318–325. https://doi.org/10.1007/s00268-008-9830-3Ferrero A., Lo Tesoriere R., Viganò L., Caggiano L., Sgotto E., Capussotti L. Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J. Surg. 2009; 33 (2): 318–325. https://doi.org/10.1007/s00268-008-9830-3Вишневский В.А., Ефанов М.Г., Икрамов Р.З., Назаренко Н.А., Шевченко Т.В., Ионкин Д.А., Чжао А.В. Отдаленные результаты радикальных и условно радикальных резекций при воротной холангиокарциноме. Анналы хирургической гепатологии. 2013; 18 (2): 9–20.Vishnevskij V.A., Efanov M.G., Ikramov R.Z., Nazarenko N.A., Shevchenko T.V., Ionkin D.A., Chzhao A.V. Long-term results after R0 and R1 resections in patients with hilar cholangiocarcinoma. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2013; 18 (2): 9–20. (In Russian)Vauthey J.N., Pawlik T.M., Abdalla E.K., Arens J.F., Nemr R.A., Wei S.H. Is extended hepatectomy for hepatobiliary malignancy justified? Ann. Surg. 2004; 239 (5): 722–730. https://doi.org/10.1097/01.sla.0000124385.83887.d5Vauthey J.N., Pawlik T.M., Abdalla E.K., Arens J.F., Nemr R.A., Wei S.H. Is extended hepatectomy for hepatobiliary malignancy justified? Ann. Surg. 2004; 239 (5): 722–730. https://doi.org/10.1097/01.sla.0000124385.83887.d5Balzan S., Belghiti J., Farges O., Ogata S., Sauvanet A., Delefosse D., Durand F. The “50-50 criteria” on postoperativeday 5: an accurate predictor of liver failure and death after hepatectomy. Ann. Surg. 2005; 242 (6): 824–828. https://doi.org/10.1097/01.sla.0000189131.90876.9eBalzan S., Belghiti J., Farges O., Ogata S., Sauvanet A., Delefosse D., Durand F. The “50-50 criteria” on postoperativeday 5: an accurate predictor of liver failure and death after hepatectomy. Ann. Surg. 2005; 242 (6): 824–828. https://doi.org/10.1097/01.sla.0000189131.90876.9eRahbari N.N., Garden O.J., Padbury R., Brooke-Smith M., Crawford M., Adam R., Koch M., Makuuchi M., Dematteo R.P., Christophi C., Banting S., Usatoff V., Nagino M., Maddern G., Hugh T.J., Vauthey J.N., Greig P., Rees M., Yokoyama Y., Fan S.T., Nimura Y., Figueras J., Capussotti L., Büchler M.W., Weitz J. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011; 149 (5): 713–724. https://doi.org/10.1016/j.surg.2010.10.001Rahbari N.N., Garden O.J., Padbury R., Brooke-Smith M., Crawford M., Adam R., Koch M., Makuuchi M., Dematteo R.P., Christophi C., Banting S., Usatoff V., Nagino M., Maddern G., Hugh T.J., Vauthey J.N., Greig P., Rees M., Yokoyama Y., Fan S.T., Nimura Y., Figueras J., Capussotti L., Büchler M.W., Weitz J. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011; 149 (5): 713–724. https://doi.org/10.1016/j.surg.2010.10.001Garcea G., Ong S.L., Maddern G.J. Predicting liver failure following major hepatectomy. Dig. Liver Dis. 2009; 41 (11): 798–806. https://doi.org/10.1016/j.dld.2009.01.015Garcea G., Ong S.L., Maddern G.J. Predicting liver failure following major hepatectomy. Dig. Liver Dis. 2009; 41 (11): 798–806. https://doi.org/10.1016/j.dld.2009.01.015Golse N., Bucur P.O., Adam R., Castaing D., Sa Cunha A., Vibert E. New paradigms in post-hepatectomy liver failure. J. Gastrointest. Surg. 2013; 17 (3): 593–605. https://doi.org/10.1007/s11605-012-2048-6Golse N., Bucur P.O., Adam R., Castaing D., Sa Cunha A., Vibert E. New paradigms in post-hepatectomy liver failure. J. Gastrointest. Surg. 2013; 17 (3): 593–605. https://doi.org/10.1007/s11605-012-2048-6Higuchi R., Yamamoto M. Indications for portal vein embolization in perihilar cholangiocarcinoma. J. Hepatobiliary Pancreat. Sci. 2014; 21 (8): 542–549. https://doi.org/10.1002/jhbp.77Higuchi R., Yamamoto M. Indications for portal vein embolization in perihilar cholangiocarcinoma. J. Hepatobiliary Pancreat. Sci. 2014; 21 (8): 542–549. https://doi.org/10.1002/jhbp.77Palavecino M., Abdalla E.K., Madoff D.C., Vauthey J.N. Portal vein embolization in hilar cholangiocarcinoma. Surg. Oncol. Clin. N. Am. 2009; 18 (2): 257–267. https://doi.org/10.1016/j.soc.2008.12.007Palavecino M., Abdalla E.K., Madoff D.C., Vauthey J.N. Portal vein embolization in hilar cholangiocarcinoma. Surg. Oncol. Clin. N. Am. 2009; 18 (2): 257–267. https://doi.org/10.1016/j.soc.2008.12.007Eshmuminov D., Raptis D.A., Linecker M., Wirsching A., Lesurtel M., Clavien P.-A. Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy. Br. J. Surg. 2016; 103 (13): 1768–1782. https://doi.org/10.1002/bjs.10290Eshmuminov D., Raptis D.A., Linecker M., Wirsching A., Lesurtel M., Clavien P.-A. Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy. Br. J. Surg. 2016; 103 (13): 1768–1782. https://doi.org/10.1002/bjs.10290Abdel-Aziz T.M.E. Novel therapeutic strategies for prevention of postresectional liver failure: dis. UCL (University College London), 2012. 206 p.Abdel-Aziz T.M.E. Novel therapeutic strategies for prevention of postresectional liver failure: dis. UCL (University College London), 2012. 206 p.Dhir M., Smith L.M., Ullrich F., Leiphrakpam P.D., Ly Q.P., Sasson A.R., Are C. Pre-operative nomogram to predict risk of peri-operative mortality following liver resections for malignancy. J. Gastrointest. Surg. 2010; 14 (11): 1770–1781. https://doi.org/10.1007/s11605-010-1352-2Dhir M., Smith L.M., Ullrich F., Leiphrakpam P.D., Ly Q.P., Sasson A.R., Are C. Pre-operative nomogram to predict risk of peri-operative mortality following liver resections for malignancy. J. Gastrointest. Surg. 2010; 14 (11): 1770–1781. https://doi.org/10.1007/s11605-010-1352-2Тупикин К.А., Коваленко Ю.А., Вишневский В.А. Новые возможности прогнозирования пострезекционной печеночной недостаточности. Анналы хирургической гепатологии. 2016; 21 (3): 70–74. https://doi.org/10.16931/1995-5464.2016370-74Тупикин К.А., Коваленко Ю.А., Вишневский В.А. Новые возможности прогнозирования пострезекционной печеночной недостаточности. Анналы хирургической гепатологии. 2016; 21 (3): 70–74. https://doi.org/10.16931/1995-5464.2016370-74 Tupikin K.A., Kovalenko Yu.A., Vishnevsky V.A. New options in prediction of post-resection liver failure. Annaly khirurgicheskoy gepatologi = Annals of HPB Surgery. 2016; 21 (3): 70–74. https://doi.org/10.16931/1995-5464.2016370-74 (In Russian)Schnitzbauer A.A., Lang S.A., Goessmann H., Nadalin S., Baumgart J., Farkas S.A., Lang H., Obed A., Schlitt H.J. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling two:staged extended right hepatic resection in small:for:size settings. Ann. Surg. 2012; 255 (3): 405–414. https://doi.org/10.1097/SLA.0b013e31824856f5Schnitzbauer A.A., Lang S.A., Goessmann H., Nadalin S., Baumgart J., Farkas S.A., Lang H., Obed A., Schlitt H.J. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling two:staged extended right hepatic resection in small:for:size settings. Ann. Surg. 2012; 255 (3): 405–414. https://doi.org/10.1097/SLA.0b013e31824856f5Schadde E., Raptis D.A., Schnitzbauer A.A., Ardiles V., Tschuor C., Lesurtel M., Abdalla E.K., Hernandez-Alejandro R., Jovine E., Machado M., Malago M., Robles-Campos R., Petrowsky H., Santibanes E.D., Clavien P.A. Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the international ALPPS registry. Ann. Surg. 2015; 262 (5): 780–785. https://doi.org/10.1097/SLA.0000000000001450Schadde E., Raptis D.A., Schnitzbauer A.A., Ardiles V., Tschuor C., Lesurtel M., Abdalla E.K., Hernandez-Alejandro R., Jovine E., Machado M., Malago M., Robles-Campos R., Petrowsky H., Santibanes E.D., Clavien P.A. Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the international ALPPS registry. Ann. Surg. 2015; 262 (5): 780–785. https://doi.org/10.1097/SLA.0000000000001450Olthof P.B., Coelen R., Wiggers J.K., Groot Koerkamp B., Malago M., Hernandez-Alejandro R., Topp S.A., Vivarelli M., Aldrighetti L.A., Robles Campos R., Oldhafer K.J., Jarnagin W.R., van Gulik T.M. High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry. HPB. 2016; 19 (5): 381–387. https://doi.org/10.1016/j.hpb.2016.10.008Olthof P.B., Coelen R., Wiggers J.K., Groot Koerkamp B., Malago M., Hernandez-Alejandro R., Topp S.A., Vivarelli M., Aldrighetti L.A., Robles Campos R., Oldhafer K.J., Jarnagin W.R., van Gulik T.M. High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry. HPB. 2016; 19 (5): 381–387. https://doi.org/10.1016/j.hpb.2016.10.008Gall T.M.H., Sodergren M.H., Frampton A.E., Fan R., Spalding D.R., Habib N.A., Jiao L.R. Radio-frequency-assisted Liver Partition With Portal Vein Ligation (RALPP) for liver regeneration. Ann. Surg. 2015; 261 (2): e45–e46. https://doi.org/10.1097/sla.0000000000000607Gall T.M.H., Sodergren M.H., Frampton A.E., Fan R., Spalding D.R., Habib N.A., Jiao L.R. Radio-frequency-assisted Liver Partition With Portal Vein Ligation (RALPP) for liver regeneration. Ann. Surg. 2015; 261 (2): e45–e46. https://doi.org/10.1097/sla.0000000000000607Мелехина О.В., Кулезнева Ю.В., Ефанов М.Г., Алиханов Р.Б, Ким П.П. Интервенционная радиология в этапном лечении пациентов с опухолью Клацкина. Московский клинический научно-практический центр. [Электронный ресурс] http://vestnik.rncrr.ru/vestnik/v16/docs/section3/Melekhina. pdf. (дата обращения 09.03.2021)Мелехина О.В., Кулезнева Ю.В., Ефанов М.Г., Алиханов Р.Б, Ким П.П. Интервенционная радиология в этапном лечении пациентов с опухолью Клацкина. Московский клинический научно-практический центр. [Электронный ресурс] http://vestnik.rncrr.ru/vestnik/v16/docs/section3/Melekhina. pdf. (дата обращения 09.03.2021) Melekhina O.V., Kulezneva Yu.V., Efanov M.G., Alihanov R.B., Kim P.P. Intervencionnaya radiologiya v etapnom lechenii pacientov s opuhol'yu Klackina [Interventional radiology in the staged treatment of patients with Klatskin tumor] Moskovskij klinicheskij nauchno-prakticheskij centr. [Electronic resource]. http://vestnik.rncrr.ru/vestnik/v16/docs/section3/Melekhina. pdf. (In Russian) (date of access 09.03.2021)Tanaka S., Hirohashi K., Tanaka H., Shuto T., Lee S.H., Kubo S., Takemura S., Yamamoto T., Uenishi T., Kinoshita H. Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J. Am. Coll. Surg. 2018; 195 (4): 484–489. https://doi.org/10.1016/s1072-7515(02)01288-7Tanaka S., Hirohashi K., Tanaka H., Shuto T., Lee S.H., Kubo S., Takemura S., Yamamoto T., Uenishi T., Kinoshita H. Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J. Am. Coll. Surg. 2018; 195 (4): 484–489. https://doi.org/10.1016/s1072-7515(02)01288-7Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004; 240 (2): 205–213. https://doi.org/10.1097/01.sla.0000133083.54934.aeDindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004; 240 (2): 205–213. https://doi.org/10.1097/01.sla.0000133083.54934.aeStrasberg S.M., Linehan D.C., Hawkins W.G. The accordion severity grading system of surgical complications. Ann. Surg. 2009; 250 (2): 177–186. https://doi.org/10.1097/SLA.0b013e3181afde41Strasberg S.M., Linehan D.C., Hawkins W.G. The accordion severity grading system of surgical complications. Ann. Surg. 2009; 250 (2): 177–186. https://doi.org/10.1097/SLA.0b013e3181afde41Kawamura T., Noji T., Okamura K., Tanaka K., Nakanishi Y., Asano T., Ebihara Y., Kurashima Y., Nakamura T., Murakami S., Tsuchikawa T., Shichinohe T., Hirano S. Postoperative liver failure criteria for predicting mortality after major hepatectomy with extrahepatic bile duct resection. Dig. Surg. 2019; 36 (2): 158–165. https://doi.org/10.1159/000486906Kawamura T., Noji T., Okamura K., Tanaka K., Nakanishi Y., Asano T., Ebihara Y., Kurashima Y., Nakamura T., Murakami S., Tsuchikawa T., Shichinohe T., Hirano S. Postoperative liver failure criteria for predicting mortality after major hepatectomy with extrahepatic bile duct resection. Dig. Surg. 2019; 36 (2): 158–165. https://doi.org/10.1159/000486906Nakanishi Y., Tsuchikawa T., Okamura K., Nakamura T., Tamoto E., Noji T., Asano T., Amano T., Shichinohe T., Hirano S. Risk factors for a high Comprehensive Complication Index score after major hepatectomy for biliary cancer: a study of 229 patients at a single institution. HPB (Oxford). 2016; 18 (9): 735–741. https://doi.org/10.1016/j.hpb.2016.06.013Nakanishi Y., Tsuchikawa T., Okamura K., Nakamura T., Tamoto E., Noji T., Asano T., Amano T., Shichinohe T., Hirano S. Risk factors for a high Comprehensive Complication Index score after major hepatectomy for biliary cancer: a study of 229 patients at a single institution. HPB (Oxford). 2016; 18 (9): 735–741. https://doi.org/10.1016/j.hpb.2016.06.013Haga Y., Miyamoto A., Wada Y., Takami Y., Takeuchi H. Value of E-PASS models for predicting postoperative morbidity and mortality in resection of perihilar cholangiocarcinoma and gallbladder carcinoma. HPB. 2016; 18 (3): 271–278. https://doi.org/10.1016/j.hpb.2015.09.00Haga Y., Miyamoto A., Wada Y., Takami Y., Takeuchi H. Value of E-PASS models for predicting postoperative morbidity and mortality in resection of perihilar cholangiocarcinoma and gallbladder carcinoma. HPB. 2016; 18 (3): 271–278. https://doi.org/10.1016/j.hpb.2015.09.00Wang H., Wang H., Chen T., Liang X., Song Y., Wang J. Evaluation of the POSSUM, P-POSSUM and E-PASS scores in the surgical treatment of hilar cholangiocarcinoma. World J. Surg. Oncol. 2014; 12 (1): 1–7. https://doi.org/10.1186/1477-7819Wang H., Wang H., Chen T., Liang X., Song Y., Wang J. Evaluation of the POSSUM, P-POSSUM and E-PASS scores in the surgical treatment of hilar cholangiocarcinoma. World J. Surg. Oncol. 2014; 12 (1): 1–7. https://doi.org/10.1186/1477-7819

The authors declare that there are no conflicts of interest present.